BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36598947)

  • 21. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.
    Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK
    Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for treating cancers with microsatellite instability.
    Yang H; Kang M; Jang S; Baek SY; Kim J; Kim GU; Kim D; Ha J; Kim JS; Jung C; Kim NJ; Cho SY; Shin WH; Lee J; Ko J; Lee A; Keum G; Lee S; Kang T
    Bioorg Med Chem; 2024 Feb; 100():117588. PubMed ID: 38295487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between methylation in mismatch repair genes, V600E BRAF mutation and microsatellite instability in colorectal cancer patients.
    Rasuck CG; Leite SM; Komatsuzaki F; Ferreira AC; Oliveira VC; Gomes KB
    Mol Biol Rep; 2012 Mar; 39(3):2553-60. PubMed ID: 21681432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.
    Burger M; Denzinger S; Hammerschmied CG; Tannapfel A; Obermann EC; Wieland WF; Hartmann A; Stoehr R
    J Mol Med (Berl); 2006 Oct; 84(10):833-41. PubMed ID: 16924473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 modulates RPA-dependent and RPA-independent WRN helicase activity.
    Sommers JA; Sharma S; Doherty KM; Karmakar P; Yang Q; Kenny MK; Harris CC; Brosh RM
    Cancer Res; 2005 Feb; 65(4):1223-33. PubMed ID: 15735006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA Mismatch Repair Deficiency Detection in Colorectal Cancer by a New Microsatellite Instability Analysis System.
    Wu S; Liu X; Wang J; Zhou W; Guan M; Liu Y; Pang J; Lu T; Zhou L; Shi X; Wu H; Liang Z; Zeng X
    Interdiscip Sci; 2020 Jun; 12(2):145-154. PubMed ID: 31983041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma.
    Matsumoto N; Yoshida T; Yamashita K; Numata Y; Okayasu I
    Br J Cancer; 2003 Aug; 89(4):707-12. PubMed ID: 12915883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells.
    Wang X; Wang J; Lin S; Geng Y; Wang J; Jiang B
    J Exp Clin Cancer Res; 2008 Sep; 27(1):44. PubMed ID: 18811981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hsp90 inhibitors promote p53-dependent apoptosis through PUMA and Bax.
    He K; Zheng X; Zhang L; Yu J
    Mol Cancer Ther; 2013 Nov; 12(11):2559-68. PubMed ID: 23966620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
    Bae JM; Cho NY; Kim TY; Kang GH
    Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Werner syndrome gene: the molecular basis of RecQ helicase-deficiency diseases.
    Shen JC; Loeb LA
    Trends Genet; 2000 May; 16(5):213-20. PubMed ID: 10782115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.
    Hu H; Kang L; Zhang J; Wu Z; Wang H; Huang M; Lan P; Wu X; Wang C; Cao W; Hu J; Huang Y; Huang L; Wang H; Shi L; Cai Y; Shen C; Ling J; Xie X; Cai Y; He X; Dou R; Zhou J; Ma T; Zhang X; Luo S; Deng W; Ling L; Liu H; Deng Y
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):38-48. PubMed ID: 34688374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers.
    Sato K; Kawazu M; Yamamoto Y; Ueno T; Kojima S; Nagae G; Abe H; Soda M; Oga T; Kohsaka S; Sai E; Yamashita Y; Iinuma H; Fukayama M; Aburatani H; Watanabe T; Mano H
    Clin Cancer Res; 2019 Jan; 25(1):378-389. PubMed ID: 30279230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
    Bubb VJ; Curtis LJ; Cunningham C; Dunlop MG; Carothers AD; Morris RG; White S; Bird CC; Wyllie AH
    Oncogene; 1996 Jun; 12(12):2641-9. PubMed ID: 8700523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
    Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
    Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
    Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
    Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Testing of expression of mismatch repair proteins in Lynch syndrome and microsatellite instability in colorectal cancer].
    Liu F; Zhang Y; Shen D; Tan D
    Zhonghua Bing Li Xue Za Zhi; 2014 Sep; 43(9):577-80. PubMed ID: 25471495
    [No Abstract]   [Full Text] [Related]  

  • 39. Mismatch repair deficiency: The what, how and why it is important.
    Olave MC; Graham RP
    Genes Chromosomes Cancer; 2022 Jun; 61(6):314-321. PubMed ID: 34837268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
    Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
    Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.